In this study, we separately evaluated the expression of CRL4–CRBN complex proteins (CRBN, DDB1, CUL4A) and their downstream targets (IKZF1, IKZF3) with IHC staining, using FFPE bone marrow samples from 130 MM patients treated with IMiDs. This evidence concerns the gene CRBN and Miyoshi myopathy.